Skip to main content Skip to section navigation Skip to footer

For healthcare professionals
For patients
For investors

Skip to main content Skip to section navigation Skip to footer

Overview
News/Events
Financial Information
Stock Data
SEC Filings
Corporate Governance
Additional Information
- Contacts
- FAQ

All SEC Filings

Investors

Overview
News/Events
Financial Information
Stock Data
SEC Filings
Corporate Governance
Additional Information
- Contacts
- FAQ

SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings

March 5, 2024 - EX-10.61 - 10-K: Annual report pursuant to Section 13 and 15(d) | Axogen, Inc. (AXGN)

March 5, 2024 > Form 10-K > Axogen, Inc.

Form: 10-K

Annual report pursuant to Section 13 and 15(d)

March 5, 2024

Documents

10-K
EX-3.2
EX-10.9 7
EX-10.9 8
EX-10.10 5
EX-10.51
EX-10.52
EX-10.53
EX-10.54
EX-10.55
EX-10.56
EX-10.57
EX-10.58
EX-10.59
EX-10.60
EX-10.61
EX-10.62
EX-10.63
EX-10.64
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-97

EX-10.61

Published on March 5, 2024

Email Alerts
Contacts
RSS News Feed
Accessibility Statement

13631 Progress Blvd, Suite 400
Alachua, FL 32615

Audience

For Healthcare Professionals
For Patients
For Investors

Resources

Privacy Policy
Terms and Conditions
Website Terms of Use
Medical Information

Corporate

About Axogen
Careers
Contact
News

© 2026 Axogen Corporation. All Rights Reserved. All trademarks are the property of their respective owners. See Trademark & Copyright Notice for details.